Extended lymphadenectomy in pancreatic cancer is crucial.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23568249.
- Also identified by DOI 10.1007/s00268-013-2039-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lymph node metastasis is considered one of the most significant factors associated with postoperative prognosis in patients with pancreatic cancer. Some prospective studies found no significant differences in survival between patients who underwent pancreatic cancer surgery with extended lymphadenectomy and those who underwent surgery with standard lymphadenectomy. However, recent reports, such as those describing the significance of the metastatic to examined lymph node ratio, suggest the need for some degree of lymphadenectomy. This review describes the findings of published studies and discusses the usefulness of LN dissection in patients with pancreatic cancer.
Medical subject headings
- Lymph Node Excision
- Pancreatic Neoplasms